Referências
Principais artigos
Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014 Jan;63(1):7-42.Texto completo Resumo
Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett's esophagus: an updated ACG guideline. Am J Gastroenterol. 2022 Apr 1;117(4):559-87.Texto completo Resumo
Fitzgerald RC. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2006 Dec;55(12):1810-20. Resumo
Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017 Feb;49(2):191-8.Texto completo Resumo
Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 2006 Nov;131(5):1392-9.Texto completo Resumo
Artigos de referência
1. Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014 Jan;63(1):7-42.Texto completo Resumo
2. Bonino JA, Sharma P. Barrett's esophagus. Curr Opin Gastroenterol. 2006 Jul;22(4):406-11. Resumo
3. Shaheen NJ. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2005 May;128(6):1554-66. Resumo
4. Flejou JF, Svrcek M. Barrett's oesophagus: a pathologist's view. Histopathology. 2007 Jan;50(1):3-14. Resumo
5. Peters JH. The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus. Surg Endosc. 2006 Apr;20(suppl 2):S456-61. Resumo
6. Sharma P. Barrett esophagus: a review. JAMA. 2022 Aug 16;328(7):663-71. Resumo
7. Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett's esophagus: an updated ACG guideline. Am J Gastroenterol. 2022 Apr 1;117(4):559-87.Texto completo Resumo
8. Fabian T, Leung A. Epidemiology of Barrett's esophagus and esophageal carcinoma. Surg Clin North Am. 2021 Jun;101(3):381-9. Resumo
9. Saha B, Vantanasiri K, Mohan BP, et al. Prevalence of Barrett's esophagus and esophageal adenocarcinoma with and without gastroesophageal reflux: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024 Jul;22(7):1381-94.e7.Texto completo Resumo
10. Cameron AJ. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus. 2002;15(2):106-8. Resumo
11. Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):432-43. Resumo
12. Fein M, Maroske J, Fuchs KH. Importance of duodenogastric reflux in gastro-oesophageal reflux disease. Br J Surg. 2006 Dec;93(12):1475-82. Resumo
13. Oh DS, Hagen JA, Fein M, et al. The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg. 2006 Jun;10(6):787-96. Resumo
14. Shalauta MD, Saad R. Barrett's esophagus. Am Fam Physician. 2004 May 1;69(9):2113-8. Resumo
15. Odze RD. Update on the diagnosis and treatment of Barrett esophagus and related neoplastic precursor lesions. Arch Pathol Lab Med. 2008 Oct;132(10):1577-85.Texto completo Resumo
16. Peters CJ, Fitzgerald RC. Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma. Aliment Pharmacol Ther. 2007 Jun 1;25(11):1253-69.Texto completo Resumo
17. Chak A, Chen Y, Vengoechea J, et al. Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):376-83.Texto completo Resumo
18. Wang DH, Souza RF. Biology of Barrett's esophagus and esophageal adenocarcinoma. Gastrointest Endosc Clin N Am. 2011;21:25-38.Texto completo Resumo
19. Fitzgerald RC. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2006 Dec;55(12):1810-20. Resumo
20. Vallböhmer D, DeMeester SR, Oh DS, et al. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus. Am J Gastroenterol. 2006 Jul;101(7):1458-66. Resumo
21. Colleypriest BJ, Farrant JM, Slack JM, et al. The role of Cdx2 in Barrett's metaplasia. Biochem Soc Trans. 2010 Apr;38(2):364-9. Resumo
22. Sikkema M, de Jonge PJ, Steyerberg EW, et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010 Mar;8(3):235-44; quiz e32.Texto completo Resumo
23. Winberg H, Lindblad M, Lagergren J, et al. Risk factors and chemoprevention in Barrett’s esophagus - an update. Scand J Gastroenterol. 2012 Apr;47(4):397-406. Resumo
24. Taylor JB, Rubenstein JH. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus. Am J Gastroenterol. 2010 Aug;105(8):1729-37.Texto completo Resumo
25. Guardino JM, Khandwala F, Lopez R, et al. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol. 2006 Oct;101(10):2187-93. Resumo
26. Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005 Dec 1;162(11):1050-61. Resumo
27. Chak A, Ochs-Balcom H, Falk G, et al. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1668-73.Texto completo Resumo
28. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 2;143(3):199-211. Resumo
29. Veugelers PJ, Porter GA, Guernsey DL, et al. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus. 2006;19(5):321-8. Resumo
30. De Jonge PJ, Steyerberg EW, Kuipers EJ, et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2006 Jul;101(7):1421-9. Resumo
31. Omer ZB, Ananthakrishnan AN, Nattinger KJ, et al. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol. 2012 Jul;10(7):722-7.Texto completo Resumo
32. Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017 Feb;49(2):191-8.Texto completo Resumo
33. National Institute for Health and Care Excellence. Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management. Feb 2023 [internet publication].Texto completo
34. Andrici J, Tio M, Cox MR, et al. Hiatal hernia and the risk of Barrett's esophagus. J Gastroenterol Hepatol. 2013 Mar;28(3):415-31. Resumo
35. Shariff MK, Bird-Lieberman EL, O'Donovan M, et al. Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. Gastrointest Endosc. 2012 May;75(5):954-61. Resumo
36. Bhardwaj A, Hollenbeak CS, Pooran N, et al. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2009 Jun;104(6):1533-9. Resumo
37. Mannath J, Subramanian V, Hawkey CJ, et al. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy. 2010 May;42(5):351-9. Resumo
38. Ngamruengphong S, Sharma VK, Das A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc. 2009 May;69(6):1021-8. Resumo
39. Qumseya BJ, Wang H, Badie N, et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2013 Dec;11(12):1562-70.e1-2.Texto completo Resumo
40. Wu J, Pan YM, Wang TT, et al. Confocal laser endomicroscopy for detection of neoplasia in Barrett's esophagus: a meta-analysis. Dis Esophagus. 2014 Apr;27(3):248-54.Texto completo Resumo
41. Waxman I, Konda VJ. Endoscopic techniques for recognizing neoplasia in Barrett's esophagus: which should the clinician use? Curr Opin Gastroenterol. 2010 Jul;26(4):352-60. Resumo
42. Nurgalieva Z, Lowrey A, El-Serag HB. The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review. Dig Dis Sci. 2007 May;52(5):1345-54. Resumo
43. Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310-30.Texto completo Resumo
44. Dickman R, Kim JL, Camargo L, et al. Correlation of gastroesophageal reflux disease symptom characteristics with long-segment Barrett's esophagus. Dis Esophagus. 2006;19(5):360-5. Resumo
45. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 2006 Nov;131(5):1392-9.Texto completo Resumo
46. Bhat SK, McManus DT, Coleman HG, et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study. Gut. 2015 Jan;64(1):20-5. Resumo
47. Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut. 2013 Jan;62(1):15-21. Resumo
48. Moyo K, Khong TK. High-dose PPI and aspirin as chemoprevention in Barrett's oesophagus. Drug Ther Bull. 2020 Mar;58(3):39-40. Resumo
49. Rubenstein JH, Sawas T, Wani S, et al. AGA clinical practice guideline on endoscopic eradication therapy of Barrett's esophagus and related neoplasia. Gastroenterology. 2024 Jun;166(6):1020-55.Texto completo Resumo
50. Wani S, Qumseya B, et al. Standards of Practice Committee. Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer. Gastrointest Endosc. 2018 Apr;87(4):907-31.e9.Texto completo Resumo
51. di Pietro M, Fitzgerald RC; BSG Barrett's guidelines working group. Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett’s oesophagus with low-grade dysplasia. Gut. 2018 Feb;67(2):392-3.Texto completo Resumo
52. Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014 Mar 26;311(12):1209-17.Texto completo Resumo
53. Qumseya BJ, Wani S, Desai M, et al. Adverse events after radiofrequency ablation in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016 Aug;14(8):1086-95.e6.Texto completo Resumo
54. Tseng EE, Wu TT, Yeo CJ, et al. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome - an update. J Gastrointest Surg. 2003 Feb;7(2):164-70. Resumo
55. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2000 Apr;118(4):670-7. Resumo
56. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009 May 28;360(22):2277-88.Texto completo Resumo
57. Rice TW, Sontag SJ. Debate: esophagectomy is the treatment of choice for high grade dysplasia in Barrett's esophagus. Am J Gastroenterol. 2006 Oct;101(10):2177-9. Resumo
58. Gilbert S, Jobe BA. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma. Surg Oncol Clin N Am. 2009 Jul;18(3):523-31. Resumo
59. Agarwal S, Alshelleh M, Scott J, et al. Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study. Gastrointest Endosc. 2022 Mar;95(3):422-31.e2. Resumo
60. ClinicalTrials.gov. Evaluation of effect of CryoBalloon focal ablation system on human esophageal epithelium (ColdPlay2). ClinicalTrials.gov identifier: NCT02534233. May 2022 [internet publication].Texto completo
61. ClinicalTrials.gov. Multi-center clinical study to evaluate the C2 CryoBalloon focal ablation system (ColdPlayIII). ClinicalTrials.gov identifier: NCT02514525. Apr 2022 [internet publication].Texto completo
62. Dulai GS, Jensen DM, Cortina G, et al. Randomized trial of argon plasma coagulation versus multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc. 2005 Feb;61(2):232-40. Resumo
63. Kastelein F, Spaander MC, Biermann K, et al. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology. 2011 Dec;141(6):2000-8.Texto completo Resumo
64. Crockett SD, Lippmann QK, Dellon ES, et al. Health-related quality of life in patients with Barrett's esophagus: a systematic review. Clin Gastroenterol Hepatol. 2009 Jun;7(6):613-23.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal